Clinical Trials Directory

Trials / Unknown

UnknownNCT04642729

Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex Smile Surgery

Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex-Smile Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Eye Hospital Pristina Kosovo · Academic / Other
Sex
All
Age
20 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to examine the effect of fresh corneal lenticule implantation as allogenic graft taken from myopic patients to implanted in patients with macular corneal dystrophy using Visumax Femtosecond Laser Smile module surgery.

Detailed description

Macular Corneal Dystrophy is a severe form of stromal corneal dystrophy characterized by bilateral cloudy regions within hazy stroma and eventually severe visual impairment. Most cases of MCD are caused by mutations in the CHST6 gene encoding a protein involved in the production of keratan sulfate, which plays a role in the maintenance of corneal transparency. According to biomechanical instability of corneal metabolism (abnormal increase collagenase activity, decrease proteinase inhibitors, excessive premature keratocyte apoptosis, increase cytokine binding) at corneal dystrophies. Fresh Corneal Lenticule and autologous serum contains live stem cells that produce keratocytes, collagen fibers, extracellular matrix which contribute to the regeneration of the cornea, and all this results at increasing of corneal transparency and visual acuity in patients with corneal macular dystrophy.

Conditions

Interventions

TypeNameDescription
PROCEDUREFresh Corneal Lenticule Implantation using Relex-Smile SurgeryKnowing that the most important element is damage of stroma we used all preoperative procedures atlas, optic tomography and especially electron microscope. Approximately we planned how much microns we remove and insert, for example we remove 80 µm and we insert fresh corneal lenticule 90 µm with the purpose to remove more dead keratocytes which increase biomechanical instability of corneal metabolism (abnormal increase collagenase activity, decrease proteinase inhibitors, excessive premature keratocyte apoptosis, increase cytokine binding). Fresh Corneal Lenticule and autologous serum contains live stem cells that produce keratocytes, collagen fibers, extracellular matrix which contribute to the regeneration of the cornea, and all this results at increasing of corneal transparency and visual acuity in patients with corneal macular dystrophy.

Timeline

Start date
2019-06-01
Primary completion
2020-06-01
Completion
2025-06-01
First posted
2020-11-24
Last updated
2024-02-20

Locations

1 site across 1 country: Kosovo

Source: ClinicalTrials.gov record NCT04642729. Inclusion in this directory is not an endorsement.